Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.045 | 0.9 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |